VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $364,000 | -2.9% | 22,838 | +5.5% | 0.02% | -20.8% |
| Q2 2017 | $375,000 | +73.6% | 21,651 | +10.5% | 0.02% | +100.0% |
| Q1 2017 | $216,000 | -58.0% | 19,600 | -44.7% | 0.01% | -61.3% |
| Q4 2016 | $514,000 | -21.5% | 35,415 | +32.7% | 0.03% | -11.4% |
| Q3 2016 | $655,000 | +26.2% | 26,697 | +3.6% | 0.04% | +20.7% |
| Q2 2016 | $519,000 | -91.6% | 25,767 | -89.1% | 0.03% | -92.7% |
| Q1 2016 | $6,197,000 | +259.0% | 235,623 | +1287.4% | 0.40% | +370.2% |
| Q4 2015 | $1,726,000 | -85.6% | 16,983 | -74.7% | 0.08% | -85.7% |
| Q3 2015 | $11,967,000 | +38.5% | 67,085 | +72.5% | 0.59% | +77.1% |
| Q2 2015 | $8,641,000 | +12.6% | 38,899 | +0.7% | 0.33% | +8.9% |
| Q1 2015 | $7,671,000 | +313.8% | 38,623 | +162.7% | 0.30% | +267.5% |
| Q2 2014 | $1,854,000 | -73.5% | 14,701 | -72.3% | 0.08% | -83.3% |
| Q1 2014 | $6,999,000 | – | 53,092 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |